Melanoma

>

Latest News

Melphalan/HDS Shows Benefit in Metastatic Uveal Melanoma
Melphalan/HDS Shows Benefit in Metastatic Uveal Melanoma

May 17th 2025

Melphalan/hepatic delivery system showed better survival and response rates than best alternative care in metastatic uveal melanoma in the FOCUS trial.

Tarhini Breaks Down RELATIVITY-047 Survival Benefits and PFS2
Tarhini Breaks Down RELATIVITY-047 Survival Benefits and PFS2

May 7th 2025

RP1 and the Future of Oncolytic Therapy in Melanoma
RP1 and the Future of Oncolytic Therapy in Melanoma

May 5th 2025

Higher ctDNA Serves as Early Warning for Melanoma Recurrence Risk
Higher ctDNA Serves as Early Warning for Melanoma Recurrence Risk

May 5th 2025

Video Series
Video Interviews
Podcasts

More News